Adicet Bio, Inc. (LON: 0HX7)
London
· Delayed Price · Currency is GBP · Price in USD 0.915
-0.022 (-2.40%)
At close: Jan 22, 2025
Adicet Bio Statistics
Total Valuation
Adicet Bio has a market cap or net worth of GBP 61.42 million. The enterprise value is -87.87 million.
| Market Cap | 61.42M |
| Enterprise Value | -87.87M |
Important Dates
The next estimated earnings date is Thursday, March 20, 2025.
| Earnings Date | Mar 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +76.93% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 62.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 0.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 1.00 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 1.27 |
Financial Position
The company has a current ratio of 10.64, with a Debt / Equity ratio of 0.09.
| Current Ratio | 10.64 |
| Quick Ratio | 10.43 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.20 |
| Interest Coverage | -42,818.41 |
Financial Efficiency
Return on equity (ROE) is -58.04% and return on invested capital (ROIC) is -35.98%.
| Return on Equity (ROE) | -58.04% |
| Return on Assets (ROA) | -33.50% |
| Return on Capital (ROIC) | -35.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -615,058 |
| Employee Count | 143 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.09% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -61.09% |
| 50-Day Moving Average | 1.00 |
| 200-Day Moving Average | 1.42 |
| Relative Strength Index (RSI) | 44.79 |
| Average Volume (20 Days) | 3,956 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.71 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -95.83M |
| Pretax Income | -87.95M |
| Net Income | -87.95M |
| EBITDA | -90.95M |
| EBIT | -95.83M |
| Earnings Per Share (EPS) | -1.16 |
Balance Sheet
The company has 150.76 million in cash and 13.58 million in debt, giving a net cash position of 137.18 million.
| Cash & Cash Equivalents | 150.76M |
| Total Debt | 13.58M |
| Net Cash | 137.18M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 157.82M |
| Book Value Per Share | 1.92 |
| Working Capital | 139.46M |
Cash Flow
In the last 12 months, operating cash flow was -68.46 million and capital expenditures -804,296, giving a free cash flow of -69.27 million.
| Operating Cash Flow | -68.46M |
| Capital Expenditures | -804,296 |
| Free Cash Flow | -69.27M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Adicet Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -76.93% |
| Shareholder Yield | -76.93% |
| Earnings Yield | -143.20% |
| FCF Yield | -112.78% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |